FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Guanfacine OK for ANDAs: FDA

Federal Register notice: FDA determines that Promius Pharmas Tenex (guanfacine HCl) tablets, 1mg, 2mg,and 3mg were not withdrawn from sale for reasons...

FDA Continues to Meet Product Review Goals: Hahn

FDA commissioner Stephen Hahn praises agency medical product review staff for maintaining the pace of reviews and actions during the pandemic.

Biologics

House Committee Wants Covid Vaccine Transparency

Democratic leaders of the House Committee on Oversight and Reform ask FDA for a briefing on plans for coronavirus vaccine transparency to build public...

Human Drugs

Covid Drug Manufacturing Guidance Explained

Two SheppardMullin attorneys discuss provisions in an FDA guidance on preventing coronavirus contamination of drugs, biologics, and APIs.

Medical Devices

Guide on Covid Effects on Device User Fee Activities

FDA issues a guidance on Effects of the COVID-19 Public Health Emergency on Formal Meetings and User Fee Applications for Medical Devices Questions a...

Medical Devices

Guide on Notifying CDRH on Discontinued Products

FDA updates a guidance entitled Notifying CDRH of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD...

Medical Devices

FDA Troubled by Chinese Firms Using Fictitious U.S. Agent

FDA faces another Covid-19 debacle as it deals with over 1,300 Chinese firms providing medical protective equipment that registered in FDAs database w...

Animal Drugs

CVM Export Certification Online System

FDAs Center for Veterinary Medicine launches its Export Certification Application and Tracking System, a new online system that allows U.S. animal foo...

Medical Devices

Comments Urge Changes to Emergency-Use Injectors Guide

Hyman, Phelps & McNamara asks FDA to provide examples to clarify specific items in the agencys draft guidance on emergency-use injectors, while the Jo...

Human Drugs

FDA Approves Karyopharm sNDA for Xpovio

FDA approves a Karyopharm Therapeutics supplemental NDA for Xpovio (selinexor), a selective inhibitor of nuclear export compound for treating adult pa...